Breakthrough T1D has restructured this opportunity into the Industry Discovery & Development Partnership (IDDP) program, which is now exclusively open to for-profit entities. Deadlines have shifted to a rolling basis, and the previous $3 million funding cap has been removed in favor of tailored budgets that require 1:1 company matching funds. Before submitting a Letter of Intent, you must now schedule a mandatory pre-LOI consultation with program staff.
Funder: Breakthrough T1D
Due Dates: Rolling (contact program staff to initiate LOI)
Funding Amounts: No set maximum; award size and duration determined by project scope, with company matching funds required.
Summary: Supports for-profit entities developing commercially viable therapies or technologies for type 1 diabetes aligned with Breakthrough T1D priorities.
Key Information: Requires company matching funds; pre-LOI discussion with Breakthrough T1D is mandatory.